HEM Pharma Inc. (KOSDAQ:376270)
South Korea · Delayed Price · Currency is KRW 33,900
0.00 (0.00%)
At close: Sep 18, 2026
HEM Pharma Market Cap
HEM Pharma has a market cap or net worth of 244.39 billion as of September 18, 2026. Its market cap has increased by 41.12% in one year.
Market Cap
244.39B
Enterprise Value
256.09B
Revenue
16.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
33,900.00
ChartMarket Cap Chart
Since November 5, 2024, HEM Pharma's market cap has increased from 114.18B to 244.39B, an increase of 114.04%. That is a compound annual growth rate of 50.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 244.39B | -25.38% |
| Dec 30, 2025 | 327.49B | 185.09% |
| Dec 30, 2024 | 114.87B | 0.61% |
| Nov 5, 2024 | 114.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 321.05B |
| DAE HWA Pharmaceutical | 207.62B |
| NOVAREX | 173.91B |
| Vivozon Pharmaceutical | 172.97B |
| CellBion | 169.32B |
| GC WellBeing | 166.45B |
| Cosmax Nbt | 152.31B |
| Kyung Dong Pharmaceutical | 147.67B |